Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort-Reference-Cited by-同舟云学术

Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort

Published:2016-05-12 Issue:2 Volume:114 Page:222-227
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Frøysnes Ida S.¹²,Larsen Stein G.³,Spasojevic Milan³,Dueland Svein⁴,Flatmark Kjersti³¹²

Affiliation:

1. Department of Tumor Biology; Norwegian Radium Hospital; Oslo University Hospital; Oslo Norway

2. Faculty of Medicine; University of Oslo; Oslo Norway

3. Department of Gastroenterological Surgery; Norwegian Radium Hospital; Oslo University Hospital; Oslo Norway

4. Department of Oncology; Norwegian Radium Hospital; Oslo University Hospital; Oslo Norway

Funder

Norwegian Cancer Association

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference36 articles.

1. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer;van Gestel;Eur J Surg Oncol,2014

2. Peritoneal carcinomatosis from colorectal cancer;Jayne;Br J Surg,2002

3. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study;Sadeghi;Cancer,2000

4. 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer;Verwaal;Ann Surg Oncol,2008

5. Improved survival in patients with peritoneal metastases from colorectal cancer: A preliminary study;Mahteme;Br J Cancer,2004

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry;European Journal of Surgical Oncology;2024-12

2. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

3. A systematic review of minimally invasive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal malignancy;ANZ Journal of Surgery;2024-05-15

4. Genetic alterations in peritoneal metastatic tumors predicted the outcomes for hyperthermic intraperitoneal chemotherapy;Frontiers in Oncology;2023-04-26

5. First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study);Frontiers in Medicine;2023-03-01